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ABSTRACT 
Biofilms are communities of microorganisms associated with surfaces encased in a 
protective extracellular matrix.  These communities often pose clinical and industrial challenges 
due to their ability to tolerate biocidal treatments and removal strategies.  Understanding the 
ecological interactions that take place during biofilm establishment is a key element for designing 
future treatment strategies.  In this work, I utilized unique methods for studying factors 
contributing to cooperative antibiotic detoxification in a polymicrobial biofilm model.  
Subsequently, I tested a novel compound mixture that exhibited promising antibiofilm properties.  
Escapin is an L-amino acid oxidase that acts on lysine to produce hydrogen peroxide (H2O2), 
ammonia, and equilibrium mixtures of several organic acids collectively called Escapin 
intermediate products (EIP).  Previous work showed that the combination of synthetic EIP and 
H2O2 functions synergistically as an antimicrobial toward diverse planktonic bacteria.  To test the 
combination of EIP and H2O2 on bacterial biofilms, Pseudomonas aeruginosa was selected as a 
model, due to its role as an important opportunistic pathogen.  Specifically, I examined 
concentrations of EIP and H2O2 that inhibited biofilm formation or fostered disruption of 
established biofilms.  High-throughput assays of biofilm formation using microtiter plates and 
crystal violet staining showed a significant effect from pairing EIP and H2O2, resulting in inhibition 
of biofilm formation relative to untreated controls or to EIP or H2O2 alone.  Similarly, flow cell 
analysis and confocal laser scanning microscopy revealed that the EIP and H2O2 combination 
reduced the biomass of established biofilms relative to controls.  Area layer analysis of biofilms 
post-treatment indicated that disruption of biomass occurs down to the substratum.  Only 
nanomolar to micromolar concentrations of EIP and H2O2 were required to impact biofilm 
formation or disruption, which are significantly lower concentrations than those causing 
bactericidal effects on planktonic bacteria. Micromolar concentrations of EIP and H2O2 combined 
enhanced P. aeruginosa swimming motility compared to either EIP or H2O2 alone. Collectively, 
these results suggest that the combination of EIP and H2O2 may affect biofilms by interfering with 
bacterial attachment and destabilizing the biofilm matrix.  
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1 INTRODUCTION  
 
1.1 Biofilms: diverse and complex communities of microorganisms 
The complexity of the microbial world is often oversimplified or misunderstood.  This 
often leads to the common misconception that microorganisms exist as pure cultures of planktonic 
cells.  Microorganisms, however, are more likely to exist in surface-attached, complex 
multispecies communities encased in a protective extracellular matrix (2).  The composition of 
this matrix varies from species to species; however, it is generally composed of lipids, 
polysaccharides, nucleic acids, and proteins.  The interplay between these components provides a 
three-dimensional structure that holds cells together (3), maintains key enzymes in their immediate 
environment (4), while providing protection from environmental threats (5).   
In addition to the complexity of the biofilm structure and composition, the diversity of 
environments in which biofilms exists are well documented (6).  From growth in hydrothermal 
vents to implanted medical devices, biofilms are able to establish and thrive in many environments.  
In many cases, however, their presence leads to economic loss (7, 8) as well as increased morbidity 
and mortality (9).                 
1.2 Antibiotic resistance: an evolutionary arms race  
The discovery and development of antibiotics has undoubtedly changed the way humanity 
has dealt with bacterial infections for nearly three-quarters of a century. Unfortunately, widespread 
and indiscreet use of these drugs over the last 50-60 years has led to the emergence of antibiotic 
resistance among previously susceptible pathogenic strains (10, 11). The emergence of multi-drug 
resistant strains has led to a push for the development of alternative methods of chemotherapeutic 
treatments with the goal of reducing the incidence of resistance (12, 13). While research for 
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alternatives is both promising and ongoing, at present, the reliance on conventional antibiotics in 
clinical settings is still high.  Chronic exposure to various types of antibiotics has provided a spark 
in an evolutionary “arms race” in which bacteria have developed mechanisms for the spread of 
resistance genes as well as stabilization of resistant phenotypes (11).  
1.3 Natural products and the emergence of anti-virulence strategies 
The increase in prevalence of bacterial strains that are resistant to current antibiotic 
treatments has led to the emergence of anti-virulence strategies that can overcome many of the 
evolutionary-driven resistance mechanisms that currently exist (14).  These strategies include 
screening small molecule libraries for antimicrobial effects (15), matrix degrading enzymes (16), 
antimicrobial surface coatings (17, 18), among others.  In general, anti-virulence strategies aim to 
disrupt mechanisms or pathways that contribute to infection and disease while minimizing the 
evolutionary triggers that lead to drug-resistance (19). 
Many of these biologically active compounds are naturally derived from vastly diverse 
sources.  For example, plant-derived compounds such as cinnamaldehyde (essential oil) have been 
shown to disrupt biofilm formation in Escherichia coli and methicillin-resistant Staphylococcus 
aureus (20, 21) and reduce virulence in Vibrio spp. by interfering with quorum-sensing 
mechanisms (22).  L-Amino acid oxidases and their enzymatic by-products, found in snake venom 
(23), the epidermal mucus of marine fish (24), and defensive secretions of marine invertebrates 
(25), have well-documented antimicrobial effects against both Gram-positive and Gram-negative 
pathogens through various mechanisms.  The identification of these biologically active compounds 
and their prospective applications as chemotherapeutic agents will provide a major boost to the 
armament of drugs currently available.   
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1.4 Objectives and hypotheses  
1.4.1 Factors affecting polymicrobial biofilm establishment 
The objective of this work is to further our collective understanding of the factors affecting 
the establishment of polymicrobial biofilms.  In many cases, the polymicrobial nature of these 
communities complicates treatment strategies and prolongs periods of disease (26).  To this end, 
we have incorporated methods for studying initial polymicrobial formation in order to test the 
following hypotheses.  1) Colonization of a surface is key during initial biofilm formation.  
Therefore it is hypothesized that polymicrobial biofilm formation by antibiotic resistant strains 
could be enhanced by increasing the areal density, or the number of attached cells per microscopic 
field.  The areal density of a constructed biofilm can be influenced by adjusting the inoculum 
density of the strains used during initial biofilm formation and thus can be used to model its overall 
impact.  2) Nutrient availability during biofilm formation could promote rapid growth of bacteria 
and ultimately influence biomass accumulation during biofilm formation.  It is hypothesized that 
this increase in biomass accumulation would result in improved antibiotic tolerance in biofilms 
grown under antibiotic challenge.  3) Antibiotic exposure during early biofilm formation has been 
known to trigger biofilm formation (27).  Thus, it was hypothesized that antibiotic exposure during 
early biofilm formation would enhance the antibiotic tolerance of strains forming biofilms under 
antibiotic challenge. 
1.4.2 The use of natural products as potential therapeutic agents 
The use of bioactive natural products with antimicrobial properties has opened new 
avenues of treatment strategies for combating antibiotic resistance.  One of these natural products 
known as escapin, is an L-amino acid oxidase that reacts with L-lysine to produce an equilibrium 
mixture of organic acids, hydrogen peroxide, and ammonium (1).  These components were found 
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to exhibit antimicrobial properties against planktonic cultures of relevant bacterial pathogens (28) 
and as a result, it was hypothesized that the same components would exhibit inhibitory or 
dispersive effects towards bacterial biofilms.  The work associated in this investigation used the 
opportunistic human pathogen Pseudomonas aeruginosa as a model.     
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2     Factors affecting early stage polymicrobial biofilm formation in the presence of 
multiple antibiotics 
2.1 Introduction 
Microorganisms are often perceived as free-floating cells that exist as single entities in 
their environment; however, they are more commonly found in structured, multispecies 
communities known as biofilms (29).  Biofilms are typically characterized by their attachment to 
surfaces (biotic and abiotic) as well as their production of an extracellular polymeric matrix in 
which the microbial community is encapsulated. This protective matrix allows microorganisms to 
withstand adverse environmental conditions including biocidal treatments (30).  Biofilms are 
ubiquitous in nature, and their presence extends to medical, environmental, and industrial settings.   
The negative impact of biofilms is of particular importance in clinical settings.  Biofilm 
communities, as well as their inherent resistance to antimicrobial agents, are at the root of many 
persistent and chronic bacterial infections (29).  For example, biofilms of the human pathogen 
Pseudomonas aeruginosa are frequently responsible for chronic infections in cystic fibrosis 
patients (31).  Another biofilm-based issue encountered in clinical settings is device-related 
infections; for example, catheter-associated infections, which are major causes of nosocomial 
bloodstream infections (32).  Additionally, multi-drug resistance often occurs once biofilms 
mature; this problem may be compounded in polymicrobial biofilms, complicating treatment (33, 
34). 
An approach to managing biofilm infections is to control early stage surface colonization. 
Factors that affect surface colonization by microorganisms include electrical charge (35), 
hydrophobicity (36) and fimbriae (37). To date, limited work has been carried out on parameters 
affecting surface colonization by more than one strain of bacterium, especially in the presence of 
6 
multiple antibiotics as are used in combination therapies (38).  In this work, we investigated factors 
affecting bacterial surface colonization in the presence of multiple antibiotics. These factors 
include 1) areal density, or the number of surface-attached cells during early stages of biofilm 
formation; 2) availability of nutrients during early attachment and its ultimate impact on biomass 
accumulation in the presence of antibiotics; and 3) how antibiotic exposure during initial biofilm 
formation impacts overall biofilm development in the presence of antibiotics.    The work expands 
on a previously established method of constructing multi-species biofilms (39) and research on the 
role of antibiotic resistance mechanisms and biofilm structure on biofilm formation by antibiotic-
sensitive and -resistant strains (40).      
2.2 Materials and Methods 
2.2.1 Strains and culture conditions 
Strains were graciously provided by H.A. O’Connell and were handled as previously 
described (41).  An antibiotic resistant strain of Escherichia coli ATCC 33456 harboring ampicillin 
resistance (Amp R) on a pUC19-based vector, pEGFP (Invitrogen, Carlsbad, CA) was used in this 
study. The pEGFP plasmid carries a gene for the green fluorescent protein (GFP) and a second 
gene coding for beta-lactamase (bla) which provides resistance to the antibiotic ampicillin. A 
second strain of E. coli, ATCC 33456 harboring spectinomycin resistance (SpecR) on a pUC18-
based vector, pUCSpec, was also used.  The pUCSpec plasmid provides resistance to the antibiotic 
spectinomycin.  Both plasmids are from the same incompatibility group which reduces the chance 
of a single cell holding both plasmids.  All inocula were prepared from stock cultures stored at -
80°C. The E. coli AmpR strain was maintained on Luria-Bertani (LB) agar containing 400 ppm 
ampicillin, and the E. coli SpecR strain was maintained on LB agar containing 100 ppm 
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spectinomycin. Both strains were cultured overnight (18-19 h) at 37ºC prior to use. Ampicillin and 
spectinomycin stocks were obtained from Sigma-Aldrich, Inc. (St. Louis, MO)  
To prepare an inoculum, several loopfuls of each E. coli strain were aseptically transferred 
from each plate to their own 1 ml of sterile 50 mM phosphate buffer (pH 7.2).  Cells were 
resuspended by vortexing and pipetting.  The optical density at 600 nm (OD600) of each overnight 
suspension was measured by spectrophotometer (Pharmacia Biotech, New York, NY) and diluted 
to achieve a 5:1 ratio of E. coli SpecR to E. coli AmpR as previously described (39).   After obtaining 
the desired optical density for the experiment, the combined inoculum was transferred into 100 ml 
of phosphate buffer or LB broth.   
2.2.2 Cultivation of biofilms 
Flow-cell cultivation of biofilms was performed according to previously described 
methods (42).  Each strain was recirculated (attachment phase) through flow cells (46 × 4 × 2 mm) 
alone or as co-cultures for 2 h in 50 mM phosphate buffer (pH 7.2)  or LB broth at a flow rate of 
0.84 ml min−1.  A 5:1 ratio of various areal densities was used for these experiments based on 
previously described methods (39).  For experiments involving antibiotic challenge during 
recirculation, 80 ppm spectinomycin + 100 ppm ampicillin were supplemented in the recirculation 
media.  Following each recirculation period, flow cells were rinsed with 50 mM phosphate buffer 
(pH 7.2) for 10 min.  For microscopic analysis at 2 h, attached cells were stained with a 50 µM 
solution of the red nucleic acid stain Syto 59 (Invitrogen, USA) for 10 min. followed by an 
additional 5 min rinse using 50 mM phosphate buffer (pH 7.2).  For 24 h biofilms, flow cells were 
re-attached and switched to a continuous phase, supplemented with LB with or without antibiotics 
(80 ppm spectinomycin + 100 ppm ampicillin) at a flow rate of 0.35 mL min−1 for the duration of 
the experiment.  Preparation for microscopic analysis after 24 h was the same as 2 h.        
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2.2.3 Microscopy and image analysis 
Colonized flow cells were imaged using a Zeiss LSM 510 confocal laser scanning 
microscope (CLSM) (Carl Zeiss, Thornwood, NY) equipped with a Fluor 40× oil immersion lens. 
Fluorescent excitation occurred simultaneously at wavelengths of 488 and 523 nm.   A minimum 
of four image stacks from each channel were taken at different locations throughout the flow cell, 
using a 1-μm z-step increment. All data points for every experiment were measured in duplicate 
or triplicate.  Quantitative analysis of image stacks was performed using the statistical package 
COMSTAT (43).  Biovolume is quantified as biomass volume divided by substratum area 
(µm3/µm2).  It provides an estimate of the biomass in the biofilm and thus it is generally referred 
to as biomass (43).   
2.2.4 Statistical analysis 
Initial mutualistic interactions were analyzed using and independent-samples Kruskal-
Wallis test (α=0.05).  Experiments of effects of areal density and antibiotic exposure were analyzed 
using a two-way analysis of variance (ANOVA) (α=0.05).   
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2.3 Results   
2.3.1 Community-dependent antibiotic tolerance and biofilm establishment 
In establishing our model for evaluating interactions leading to biofilm establishment under 
challenging conditions, we initially screened concentrations of antibiotics that were inhibitory and 
suitable for our experiments.  Concentrations of 80 ppm spectinomycin and 100 ppm ampicillin 
were selected based on these preliminary experiments.  To demonstrate these interactions, each E. 
coli strain was recirculated independently of the other as well as in combination for 2 h in 
phosphate buffer, allowing colonization of the flow cell.  A ratio of 5:1 E. coli SpecR to E. coli 
AmpR  was used, with an approximate areal density of 600 cells (combined) and 500 (SpecR) and 
100 (AmpR) cells  separately.  Subsequently, the cells were grown in LB + antibiotics for 24 h and 
analyzed for biomass accumulation.  CLSM and image analysis from 24 h biofilms indicated that 
combined cultures of each E. coli strains resulted in significantly greater biomass accumulation 
than each strain alone, in the presence of both antibiotics relative to untreated controls (Fig. 2.1A 
and B).   These observations suggested that a favorable interaction between both strains in co-
culture allowed for biofilm formation to occur in the presence of a dual antibiotic challenge.  
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Figure 2.1: Community-dependent biofilm establishment under antibiotic 
challenge. (A) Top panel shows representative CLSM images of E. coli SpecR and E. 
coli AmpR alone and in co-cultures, recirculated in phosphate buffer for 2 h. E. coli 
SpecR appears red due to nucleic acid stain Syto 59, E. coli AmpR appears green due 
to ampicillin-induced expression of green fluorescent protein (GFP).    Bottom panel 
represents growth condition in LB (± antibiotics) after 24 h. (B) The image analysis 
software package COMSTAT was used for biomass determination and all conditions 
were normalized to untreated controls.  Values for each condition are means ± 
standard error of the means for 2-3 replicates of each condition. An independent-
samples Kruskal-Wallis test indicated a significant effect of culture condition (χ2(2) = 
9.293, p<0.05) at 24 h. Asterisks indicate that mean rank values of E .coli SpecR and 
E .coli AmpR are significantly different from the combined culture and untreated 
controls. 
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2.3.2 Effects of areal density and antibiotic exposure on biofilm formation under antibiotic 
challenge: phosphate-recirculated cells  
We hypothesized that three factors during recirculation (attachment) contributed to biofilm 
growth by both E. coli strains in the presence of two inhibitory antibiotic concentrations, as seen 
in Figure 2.1. These factors were areal density, the presence or absence of antibiotics, and the 
presence or absence of nutrients.  To determine the effect of areal density on biofilm growth, co-
cultured inocula of E. coli SpecR and E. coli AmpR were recirculated for 2 h in phosphate buffer 
in the presence or absence of 80 ppm spectinomycin and 100 ppm ampicillin.  The areal cell 
densities selected for these experiments were 600, 900, and 1200 cells per microscopic field, 
corresponding to x, y, and z cells mm-2 respectively.   Additionally, based on optimal conditions 
in previous findings (39) a 5:1 ratio of E. coli SpecR to E. coli AmpR was maintained with all 
experiments.   After the 2 h recirculation phase, attached cells were irrigated for 24 h with either 
LB or LB supplemented with antibiotics (80 ppm spectinomycin + 100 ppm ampicillin).  CLSM 
and image analysis indicated no significant main effects of areal density or antibiotic exposure 
(during recirculation) on biofilm biomass accumulation after 24 h, relative to controls (p > 0.05; 
Fig. 2.2 A and B).  This suggests that regardless of the areal density tested, using a 5:1 ratio at each 
one was sufficient in overcoming any adverse effects of antibiotic exposure during attachment and 
the 24 h period of biofilm development under antibiotic challenge.  This may further suggest that 
the importance of the community-dependent interactions that occur under challenging conditions 
lies in the composition of the members of the biofilm community and their proximity to one 
another.   
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Figure 2.2: Effects of areal density and antibiotic exposure on phosphate-
recirculated cells in 24 h biofilm formation.  (A) Top panel shows representative 
CLSM images of E. coli SpecR and E. coli AmpR co-cultures at a 5:1 ratio (~1200 
cells), recirculated in phosphate buffer (+ antibiotics) for 2 h and grown in LB (± 
antibiotics) for 24 h.  Bottom panel is the same, except cells were recirculated in 
phosphate buffer (-antibiotics).  E. coli SpecR appears red due to nucleic acid stain 
Syto 59, E. coli AmpR appears green due to ampicillin-induced expression of 
green fluorescent protein (GFP). (B) The image analysis software package 
COMSTAT was used for biomass determination and all conditions were 
normalized to untreated controls.  Values for each condition are means ± standard 
error of the means for 3 replicates of each condition. Two-way ANOVA indicated 
no significant main effects of either areal density or recirculation conditions. In 
addition, no significant interaction between areal density and recirculation 
conditions was determined.          
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2.3.3  Effects of areal density and antibiotic exposure on biofilm formation under 
antibiotic challenge: LB-recirculated cells  
To determine whether the presence of nutrients during attachment impacted biofilm 
formation, co-cultures of E. coli SpecR and E. coli AmpR were grown as described in Section 2.3.2 
except that LB broth was provided during the 2 h recirculation. CLSM and image analysis 
indicated a significant main effect of recirculation conditions (p < 0.05), but no significant effect 
of areal density (p > 0.05).  These data indicated that there was a significant difference in untreated 
controls (no antibiotics at 2 and 24 h) and those that were recirculated in the presence or absence 
of antibiotics, followed by a 24 h antibiotic challenge (Fig. 2.3 A and B). Nutrient availability 
during the attachment phase, coupled with antibiotic exposure, did not appear to enhance antibiotic 
tolerance during the following 24 h growth, relative to co-cultures recirculated in the absence of 
antibiotics.  Although nutrient availability during the attachment phase generally results in greater 
overall biomass, it does not necessarily result in a significant advantage during biofilm 
development under antibiotic challenge.    
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Figure 2.3: Effects of areal density and antibiotic exposure on LB-
recirculated cells in 24 h biofilm formation.  (A) Top panel shows 
representative CLSM images of E. coli SpecR and E. coli AmpR co-cultures at a 
5:1 ratio (~1200 cells), recirculated in LB (+ antibiotics) for 2 h and grown in LB 
(± antibiotics) for 24 h.  Bottom panel is the same, except cells were recirculated 
in LB (-antibiotics).  E. coli SpecR appears red due to nucleic acid stain Syto 59, 
E. coli AmpR appears green due to ampicillin-induced expression of green 
fluorescent protein (GFP). (B) The image analysis software package COMSTAT 
was used for biomass determination and all conditions were normalized to 
untreated controls.  Values for each condition are means ± standard error of the 
means for 3 replicates of each condition. Two-way ANOVA indicated no 
significant effect of the areal density factor (F [2, 96] = 0.190, p>0.05), but a 
significant main effect of recirculation condition (F [2, 96] = 13.99, p<0.05); post 
hoc tests show that untreated controls (no antibiotics at 2 and 24 h) were 
significantly different from cells recirculated with our without antibiotics at 2 h 
but challenged with antibiotics for 24 h (p<0.05). No significant interaction 
between areal density and recirculation conditions was determined (F [4, 96] = 
0.295, p>0.05).            
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2.4 Discussion 
The conditions present during substratum colonization are important factors in biofilm 
formation, particularly in the presence of multiple antibiotics.  The biofilm structure is inherently 
resistant to biocidal treatments (5) and creates treatment hurdles that are further compounded by 
the presence of antibiotic resistant populations within the biofilm community.  Community-
dependent antibiotic resistance allows for multiple members of a microbial community, each 
harboring a unique antibiotic resistance gene, to coexist in close proximity in the presence of 
inhibitory concentrations of antibiotics.  In evaluating these ecological interactions, it was 
determined that the ability of antibiotic resistant co-cultures to establish biofilms under antibiotic 
challenge occurred independently of areal density (i.e. number of attached cells during 
recirculation).  We suspect that the alleviation of the effects of antibiotic exposure is related to two 
factors. This first is the proximity of each resistant cell type to one another, which facilitates the 
likelihood of a mutual antibiotic detoxification event to take place.  These types of interactions 
were similarly observed by O’Connell and colleagues (40).  The second factor is initiation of a 
stringent response simulated by recirculation in phosphate buffer.  The stringent response is a low-
nutrient stress response, which among others things, has been shown to regulate biofilm formation 
in E. coli (44, 45).  Phosphate-recirculated cells experience a period of starvation during the 
attachment phase that may serve as an environmental trigger towards biofilm formation.  This 
occurs regardless of antibiotic exposure during the same period.  Once cells were switched over to 
a growth medium, biomass accumulation remains similar among all conditions after 24 h, perhaps 
due to a slower growth rate of the cells in the biofilm as well as residual effects of the antibiotics.  
It should also be noted that phosphate-recirculated cells grown in LB + antibiotics for longer 
periods (~ 48 h) resulted in greater biomass accumulation (39), suggesting that even in the presence 
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of an antibiotic challenge, given enough time, cooperative antibiotic detoxification will occur 
resulted in greater biomass.  
  In contrast to the nutrient-poor conditions modeled during phosphate recirculation, 
nutrient-rich conditions (LB) during the attachment phase generally resulted in increased biomass 
accumulation after 24 h.  This was not totally unexpected since nutrient availability during the 
attachment phase would lead to rapid cell division and ultimately greater biomass accumulation 
after 24 h, when compared to phosphate-recirculated cells.  However, the presence or absence of 
antibiotics during recirculation did not significantly help or hinder biofilm formation (24 h) under 
antibiotic challenge.  Initially it was hypothesized that antibiotic exposure during the attachment 
phase might enhance biofilm formation by acting as an environmental cue, triggering cells to enter 
into the more protective biofilm phenotype.  This type of reaction to inhibitory concentrations of 
antibiotics has been previously documented in both E. coli and P. aeruginosa and is linked to 
secondary messenger systems like cyclic-di-GMP (27).  However, these findings seem to indicate 
that under nutrient-rich conditions the cells exposed to antibiotics do not fare any better than their 
counterparts which go unchallenged during attachment.  Nutrient availability, in fact, may actually 
serve as a disadvantage to cells that experience antibiotic challenge.  As it turns out, one of the key 
characteristics that allows members of a biofilm to resist antimicrobial treatments is reduced 
metabolic activity (46).  Interestingly, Barraud et al. (47) similarly described how exposure to 
mannitol enhanced the metabolic activity of P. aeruginosa biofilm cells and subsequently 
enhanced their susceptibility to antibiotic treatment.       
Although certain patterns were observed in our analysis of parameters like areal density 
and antibiotic exposure, these patterns did not reveal any discernable significance within the scope 
of our model.  However, modifications to future experiments may help shed further light on the 
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interplay between these factors.  Additionally, nutrient availability, antibiotic exposure, and areal 
density are certainly factors of clinical relevance when considering the ecological interactions that 
occur in chronic infections caused by biofilms; however, one should also consider these parameters 
when considering the use of biofilms as industrial catalyst.  Conditions that initiate or promote 
biofilm formation could be essential in biofilm reactor design and ultimately yield of final products 
or removal of wastes (48).   
The highlight of this method lies in its simplicity and reproducibility.  The ability to 
construct in vitro models of microbial biofilms of both clinical and industrial relevance can help 
bridge the gap between bench-scale investigations and the ultimate application of therapeutic 
strategies and full-scale industrial applications.          
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3 Inhibition and dispersal of Pseudomonas aeruginosa biofilms by combination 
treated of Escapin intermediate products and hydrogen peroxide. 
3.1 Introduction 
In their natural environments, microorganisms most frequently exist as biofilms, or 
communities of microorganisms attached to surfaces and encased in a self-produced extracellular 
matrix (29).  The properties of this matrix afford these microorganisms protection from 
environmental challenges including nutritional starvation and chemical treatments such as 
antibiotics.  Biofilms have a well-documented impact in both industrial and clinical settings.  In 
microbial infections, the protective and recalcitrant nature of the biofilm state leads to problems 
with treatment and clearance.  Biofilms on medical devices such as catheters or implants can result 
in chronic infections that are resistant to therapeutic drugs (49, 50).  Nosocomial infections, often 
associated with biofilm formation on medical devices or wound sites, contribute to higher 
morbidity and mortality rates as well as increased healthcare costs (50, 51).  Industries such as 
wastewater treatment as well as food and agriculture are heavily impacted by the adverse effects 
of biofilms as well (52, 53).  Consequently, the search for effective anti-biofilm strategies is an 
ongoing quest that looks to both natural and synthetic agents that are capable of preventing, 
disrupting, or eradicating biofilms, while reducing selective pressures that contribute to resistance.      
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An effective antimicrobial agent against planktonic microbes has been found in the ink of 
the marine gastropod mollusc Aplysia californica (sea hare) (54).  The ink is the product of two 
simultaneously released glandular secretions; upon attack by predators, the sea hare releases both 
products into the mantle cavity where they are mixed before being ejected from the animal (55, 
56).  One of the bioactive ingredients in the secretion is Escapin, an L-amino acid oxidase (25).  
Escapin and its major natural substrate, L-lysine, are secreted at nearly 2 mg/ml and 150 mM 
respectively (57-59).  A series of Escapin-catalyzed and non-enzymatic chemical reactions yields 
an equilibrium mixture of a diverse set of molecules referred to as Escapin intermediate products 
(EIP), which can be synthesized and are effective as naturally produced products (Fig. 3.1) (1, 60).  
Hydrogen peroxide (H2O2) and ammonium are also produced.  The equilibrium among the 
components of EIP is dependent on pH, with the cyclic form, compound 3, dominating at any pH.   
The combination of EIP and H2O2, annotated as “EIP + H2O2” throughout this work, is 
bactericidal against a wide range of planktonic microbes including Gram-negative and Gram-
positive bacteria, yeast, and fungi (1, 25).  At low millimolar concentrations, EIP + H2O2 produces 
rapid, powerful, and long lasting bactericidal activity against planktonic cells, probably through 
condensation of DNA (1, 28).  EIP + H2O2 is an especially effective agent against planktonic 
cultures of P. aeruginosa (1).  Given the bactericidal effects of EIP + H2O2 against planktonic 
bacteria, and in particular P. aeruginosa, we focused on the effectiveness of EIP + H2O2 against 
bacterial biofilms.  P. aeruginosa is a well-known opportunistic pathogen whose biofilms cause 
chronic infections, morbidity, and mortality (61-63).  Taking into account the effectiveness of EIP 
+ H2O2 against this bacterium (1) and its clinical relevance as a formidable pathogen, the objective 
of this study was to determine the effectiveness of EIP + H2O2 in preventing the formation of and 
disrupting existing biofilms of P. aeruginosa.   
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3.2 Materials and Methods 
3.2.1 Culture preparation 
Pseudomonas aeruginosa PAO1 was grown in Pseudomonas Basal Mineral Medium, 
supplemented with glucose (80 mM final concentration) (PBM-glucose) (64) at 37 °C with shaking 
at 200 rpm for 16-18 h.  Frozen stocks (10% glycerol/-80 °C) were thawed and 35 μl were added 
Figure 3.1: Summary of the chemistry of the reaction of Escapin with L-lysine, 
including the effects of pH on the relative composition of the molecular species in 
the equilibrium mixture.  Figure reprinted with permission from Ko et.al. 2008 (1). 
Compounds are: L-lysine (compound 1), α-keto-ε-aminocaproic acid (compound 2), Δ1-
piperideine-2-carboxylic acid (compound 3), Δ2-piperideine-2-carboxylic acid 
(compound (4), γ-aminovaleric acid (compound 5), γ-valerolactam (compound 6), 6-
amino-2-hydroxy-hex-2-enoic acid (compound 7), 6-amino-2,2-dihydroxy-hexanoic 
acid (compound 8), and 2-hydroxy-piperidine-2-carboxylic acid (compound 9).  
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to 30 ml of PBM-glucose in a 50 ml flask.  Overnight cultures were diluted with fresh PBM-
glucose to obtain initial inoculum densities of OD600 = 0.01 or 0.10 for biofilm formation and 
dispersal assays, respectively.  
3.2.2 Chemicals 
Escapin intermediate products (EIP) was synthesized as described in Kamio et al. (60) 
based on Lu and Lewin (65) using a non-enzymatic synthesis starting with pipecolinic acid ethyl 
ester.  Δ1-Piperidine-2-carboxylic acid (compound 3) is the major product and Δ2-piperidine-2-
carboxylic acid (compound 4) is the minor product of this synthesis, though in solution, 
compounds 3 and 4 form an equilibrium mixture with other compounds, as shown in Figure 3-1.  
The preparation of EIP used in each treatment is derived from the synthetic preparation of 𝜟1-
piperidine-2-carboxylic acid and used as the initial molecule to generate the EIP equilibrium 
mixture. This synthesis allows for the independently controlled presentation of these two major 
components of Escapin’s products, EIP and H2O2.  Freeze-dried EIP was stored at -80 °C and 
dissolved in sterile deionized (DI) water as a 1 M stock and diluted at the time of experiment.  
Hydrogen peroxide (H2O2, 30%) was purchased from Fisher Scientific (Cat. No. H325-100).  For 
experiments, treatment concentrations of EIP and H2O2 were prepared in Pseudomonas Basal 
Mineral Medium without glucose (PBM-no glucose) in order to prevent further growth during 
treatment periods. 
Live/Dead® BacLight™ Bacterial Viability Kit (L-7012) was purchased from Life 
Technologies (CA, USA).  This kit includes two different nucleic acid stains: SYTO 9® and 
propidium iodide (PI).  SYTO 9® is a green-fluorescent dye that labels bacteria with either intact 
or damaged membranes.  PI is a red-fluorescent dye that can only penetrate bacteria with damaged 
membranes and that reduces SYTO 9® fluorescence when both dyes are present. 
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3.2.3 Assay of biofilm formation 
Biofilms were cultured in 96-well polystyrene microtiter plates (20, 66, 67) using PBM-
glucose as the growth medium.  Briefly, biofilms were grown for 5 h (attachment phase) in the 
presence of EIP + H2O2, EIP alone, H2O2 alone, and PBM-glucose alone as the control.  After 
incubation and treatment periods, biofilms were rinsed with sterile, deionized (DI) water by 
consecutively submerging microtiter plates in three separate tubs for 10 sec each, followed by 
shaking out extra water.  The biofilms were stained with 125 μl of 0.02% crystal violet (125 μl 
0.3% crystal violet (Becton Dickinson, NJ) in 2 ml DI water) for 15 min at room temperature with 
shaking at 200 rpm.  After staining, 96-well plates were rinsed with DI water three times.  Plates 
were allowed to air dry for a minimum of 1 h or overnight.  For quantification, bound crystal violet 
was dissolved with 125 μl of 95% ethanol for 30 min at room temperature with shaking at 200 
rpm.  Absorbance of dissolved crystal violet was measured by spectrophotometer at 570 nm using 
95% ethanol as the blank.  Treatment conditions were normalized to untreated controls and biofilm 
inhibition, as determined by biomass accumulation, is expressed as biomass (% control).   
3.2.4 Assay of biofilm dispersal 
Biofilms were grown in flow cells as described previously (20, 42, 68) using PBM-glucose 
as the growth medium.  Frozen stocks of strain PAO1 were inoculated (35 μl added to 30 ml 
medium) into PBM-glucose in a 50 ml flask and incubated at 37 °C with shaking at 200 rpm for 
16-18 h. The overnight culture was diluted with fresh PBM-glucose to obtain an OD600 of 0.10.  
Biofilms were grown in flow cells for 20 h in recirculation mode and were rinsed for 20 min with 
PBM-no glucose (rinse buffer).  Biofilms were then treated with EIP + H2O2, EIP alone, H2O2 
alone, or a PBM-no glucose control for 30 min followed by a 10 min rinse with PBM-no glucose 
prior to staining.  One ml of a staining solution consisting of LIVE/DEAD® BacLight™ Bacterial 
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Viability Kit (3.34 µM SYTO 9 and 20 µM propidium iodide) was used to stain the biofilm for 15 
min, followed by a 5 min rinse with PBM-no glucose.  Microscopic imaging of each flow cell was 
performed using a Zeiss LSM 510 confocal laser-scanning microscope (Carl Zeiss, Thornwood, 
NY).  A minimum of 10 image stacks with a 1 μm z-step were taken for each channel of the flow 
cell using a 40× oil immersion lens.  The excitation/emission wavelengths of 480/500 nm and 
490/635 nm were used for SYTO 9 and propidium iodide, respectively, using argon and helium-
neon (HeNe) lasers.  Quantitative analysis of image stacks was performed using the statistical 
package COMSTAT (43).  Biovolume is quantified as biomass volume divided by substratum area 
(µm3/µm2).  It provides an estimate of the biomass in the biofilm and thus it is generally referred 
to as biomass (43).  Area layer is the fraction of the area occupied by biomass (%) in each image 
of a stack (i.e. distance from the substratum (µm)) (43).  Image stacks are 1 µm slice images that 
are stacked by the CLSM program to generate a three dimensional image of the biofilm.  Area 
layer analysis determines what fraction of each 1-µm slice is occupied by biomass from the 
substratum to the apex of the biofilm.  
3.2.5 Motility assays 
Motility assays were performed as described previously (69, 70) with some modification.  
Media used for the assay was Luria-Bertani (LB) broth, Miller (Difco) (tryptone 10 g/l, yeast 
extract 5 g/l, sodium chloride 10 g/l) (Fisher Scientific Cat. No. DF0446-07-5) containing 0.3% 
(wt/vol) Bacto agar (Fisher Scientific Cat. No. DF0140-15-4) for swimming, 0.5% (wt/vol) Bacto 
agar for swarming, and 1% (wt/vol) for twitching plates.  For initial screens of effects of EIP on 
motility, 10 µl of either PBM-no glucose (control) or various concentrations of EIP (50, 100, 200, 
400, 800, 1000 µM) (treatment) were spotted at the center of each corresponding motility plate 
and allowed to dry for approximately 5-10 min prior to inoculating bacteria.  In subsequent 
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swimming motility experiments, EIP (50 µM or 100 µM), H2O2 (3 µM or 6 µM), or EIP + H2O2 
(3 µM H2O2 + 50 µM EIP or 6 µM H2O2 +100 µM EIP) were applied to each plate in the same 
manner.  To account for the single 10 µl application of EIP and H2O2, as compared to the constant 
flow presented in flow cell treatments, higher concentrations of each compound were tested, also 
taking into account diffusion of the compound through the agar matrix as well as the possibility of 
chemical instability.  Swimming and swarming plates were gently inoculated at the agar surface 
at the center of each plate with bacteria from an overnight culture streaked on LB agar plates (1.5% 
wt/vol) using sterile toothpicks.  Twitching plates were inoculated by stabbing the toothpick 
through the agar at the center of each plate, making sure to make contact with the bottom surface 
of the plate.   Plates were sealed with Parafilm to prevent dehydration and incubated at 37°C for 
24 h.  The diameter (measured in mm) of the motility zone was measured at intervals of 2, 4, and 
24 h and used to determine the area (mm2) of the zone.  Treatments were normalized to the mean 
values for each replicate of the untreated controls and motility zones are expressed as area (% 
control).  
3.2.6 Statistical analysis 
Prevention of biofilm formation was analyzed using two-way analysis of variance 
(ANOVA) (α=0.05).  Analysis of biofilm dispersal and undamaged/damaged ratios were done 
using one-way ANOVA (α=0.05).  A repeated measures ANOVA (α=0.05) was used in 
analyzing area layer data.  Motility experiments were analyzed using an independent-samples t 
test (α=0.05) and independent-samples Kruskal-Wallis test (α=0.05). 
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3.3 Results 
3.3.1 EIP + H2O2 in combination inhibit P. aeruginosa biofilm formation at micromolar 
concentrations 
Preliminary data collected to determine effective concentrations of EIP and H2O2 for 
biofilm prevention studies indicated that micromolar concentrations of both EIP and H2O2 were of 
particular interest.  To examine these conditions further, P. aeruginosa was grown in microtiter 
plates for 5 h, simulating the attachment phase of the biofilm life cycle, in the presence of varying 
concentrations of H2O2 alone, EIP alone, or EIP + H2O2 (Fig. 3.2).  H2O2 alone resulted in reduced 
biofilm formation, particularly at the concentrations of 48 µM and 96 µM which resulted in an 
approximate 44% and 30% reduction in biomass, respectively, relative to untreated controls.  EIP 
alone, at either 3 µM or 30 µM, resulted in 25% and 17% less biofilm formation respectively, 
compared to untreated controls.  EIP + H2O2, at H2O2 concentrations ≥ 24 µM, resulted in up to 
47% less biofilm formation relative to untreated controls.  The greatest effect on biofilm formation 
was observed when EIP was paired with 96 µM H2O2, resulting in more than 65% less biofilm 
formation, relative to untreated controls.  Two-way ANOVA indicated a significant treatment 
effect (H2O2, 3 μM EIP + H2O2, 30 μM EIP + H2O2) and a significant concentration effect (H2O2 
at 0 to 96 μM) but a non-significant treatment-concentration interaction.  Post hoc analysis of the 
treatment effect indicated that combination treatment of EIP (3 µM or 30 µM) + H2O2 resulted in 
significantly less biofilm formation than single treatments.  Post hoc analysis of the H2O2 
concentration effect showed that higher concentrations resulted in significantly less biofilm 
formation than lower concentrations.  Thus, while EIP and H2O2 alone only resulted in 20 to 30% 
less biofilm formation than the untreated controls, EIP (3 µM or 30 µM) + H2O2 (96 µM) resulted 
in nearly 70% less biofilm formation than the control.  The effects of EIP and H2O2 were assessed 
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after 12 h to determine if inhibition of biofilm formation was maintained (data not shown).  
However, the inhibitory effects diminished over this period, most likely due to a reduction in the 
chemical stability of the EIP.  
 
 
 
 
Figure 3.2: Effects of EIP and H2O2 on P. aeruginosa biofilm formation.   
P. aeruginosa biofilms were grown for 5 h in the presence of varying concentrations 
of: H2O2 alone (black bars); 3 µM EIP alone or in combination with H2O2 alone 
(gray bars); or 30 µM EIP alone or in combination with H2O2 (white bars).  Negative 
control (untreated) was PBM-glucose.  Prevention of biofilm formation was 
determined by 96-well microtiter plate crystal violet assay.  The values for each 
treatment including control (PBM-glucose) are means ± standard errors of the means 
for three replicates for each experimental condition.  Total number of measurements 
for each treatment ranged from 23-48.  Two-way ANOVA indicated a significant 
effect for the treatment factor (F [2,473] = 18.57, p<0.05); post hoc tests show that the 
H2O2 alone treatment is significantly different from H2O2 + 3 µM EIP and H2O2 + 
30 µM EIP (p<0.05).  Additionally, a significant effect was determined for the H2O2 
concentration factor (F [6,473] = 11.43, p<0.05; post hoc tests show that the values for 
0 µM =3 µM = 6 µM (a) > 12 µM = 24 µM (b) > 48 µM = 96 µM (c).  The interaction 
between the treatment factor and the H2O2 concentration factor was not significant 
(F [12,473] = 0.91, p>0.05).    
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3.3.2 EIP and H2O2 work synergistically to disperse P. aeruginosa biofilms  
To examine the dispersal effects of EIP + H2O2 on established biofilms, a range of 
concentrations of H2O2 plus one concentration of EIP (50 µM) were tested using biofilms 
cultivated in flow cells for 20 h.  Preliminary experiments (data not shown) indicated various EIP 
concentrations (above and below our treatment condition) that resulted in biofilm disruption; a 
concentration of 50 µM resulted in more pronounced disruption when paired with H2O2 and thus 
was selected as the treatment concentration.  Representative CLSM images of 20 h old biofilms 
treated with 3 µM H2O2 alone, 3 µM H2O2 + 50 µM EIP, and 50 µM EIP alone show the disruptive 
effects of the combined treatment versus H2O2 or EIP alone (Fig. 3.3A).  The combined treatment 
resulted in greater biomass clearance (indicated by black color (no cells)) and less stained biomass 
(yellow) compared to the control and other treatments (Fig. 3.3A).  One-way ANOVA showed 
that combination treatments, including the combinations of 50 µM EIP plus either 0.03 µM H2O2 
or 3 µM H2O2, but not the respective single treatments, significantly reduced biofilm biomass, by 
42% and 37% respectively, relative to control levels (Fig. 3.3B).  Treatments with 30 µM and 300 
µM H2O2 alone, were not significantly different than their corresponding combined treatments 
with 50 µM EIP, suggesting a small window of concentrations ranges in which synergistic effects 
take place.        
 
 
28 
 
3.3.3 Treatment with EIP or EIP + H2O2 disperses but does not increase membrane 
damage within P. aeruginosa biofilm. 
The ability of EIP + H2O2 to cause membrane damage and impact viability of biofilm cells 
was assessed by measuring the ratio of green to red stained cells in biofilm images collected by 
CLSM.  One-way ANOVA indicated that treatment with 3 µM H2O2 + 50 µM EIP or 50 µM EIP 
alone significantly reduced biofilm biomass compared to untreated controls and treatments with 3 
Figure 3.3: Effects of EIP on P. aeruginosa and biofilm cell viability and biomass.   
Representative confocal microscopy images of 20 h P. aeruginosa biofilms following treatment with 3 
µM H2O2 alone, 50 µM EIP alone, 3 µM H2O2 + 50 µM EIP, and control (PBM-no glucose). Shown is 
cell viability labeling using LIVE/DEAD® BacLight™ nucleic acid stain where green labeling 
represents live and undamaged cells, red labeling represents cells that are dead or with damaged 
membranes, yellow represents areas where green and red labeling are co-localized in the biofilm and 
black labeling represents area without cells.  Bottom panel shows representative 3-dimensional 
projections of the representative confocal images. Scale bar, 50 µm. (B) Effects of EIP + H2O2 against 
P. aeruginosa biofilm (i.e. biofilm disruption).  Flow-cell cultivated P. aeruginosa biofilms (20 h) were 
analyzed post-treatment by CLSM.  The image analysis software package COMSTAT was used for 
biomass determination and all treatments were normalized to untreated controls.  Open diamond is 
untreated control; open square is 50 µM EIP alone; open circles are H2O2 alone; closed circles are EIP + 
H2O2. Values are means ± standard errors of the means for three replicates for each experimental 
condition. A range of 5 to 10 image stacks were taken for each biofilm; the total number of measurements 
for each treatment ranged from 4-172. ANOVA showed that the 7 treatments significantly differ in their 
effect on biofilm biomass (F [12,472] = 8.21, p<0.05), and post hoc tests show that EIP + H2O2 but not EIP 
or H2O2 is significantly different from the control (p<0.01).  Asterisks indicate that the value of the EIP 
+ H2O2 at concentrations of 0.03 µM or greater and H2O2 alone at 30 µM and 300 µM is significantly 
lower than that of untreated control and EIP + H2O2 at concentrations ≤ 0.003 µM.     
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µM H2O2 alone (Fig. 3.4A).  Measurements of green and red biomass from these treatments were 
used to determine a ratio of undamaged to damaged cells to determine the impact of treatment on 
membrane integrity (Fig. 3.4B). An undamaged/damaged ratio less than one is indicative of a 
greater presence of damaged cells.  The undamaged/damaged ratios for all treatments, including 
the untreated control, were all greater than two, suggesting that the effects of the treatments did 
not result in increased membrane damage to the biofilm cells.  The undamaged/damaged ratios for 
3 µM H2O2 + 50 µM EIP and 3 µM H2O2 were not significantly different from the untreated 
control, and the undamaged/damaged ratio for 50 µM EIP was significantly greater than all other 
treatments.  Taken together with our other results, these experiments support the idea that EIP and 
H2O2 are dispersive, but not through a mechanism of membrane damage. 
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Figure 3.4:  Effects of EIP and H2O2 on P. aeruginosa biofilm disruption. (A) Flow-cell cultivated biofilms were 
analyzed post-treatment by CLSM.  The image analysis software package COMSTAT was used for biomass 
determination and all treatments were normalized to untreated controls. Values are means ± standard errors of the 
means for three replicates. Ten image stacks were taken for each biofilm; the total number of measurements for each 
treatment ranged from 30-109.  ANOVA showed that two treatments significantly differ in their effect on biofilm 
biomass (F [3,205] = 10.24, p<0.05); post hoc tests show that 3 µM H2O2 + 50 µM EIP and 50 µM EIP but not 3 µM 
H2O2 are significantly different from the control (p<0.05).  Asterisks indicate that the values for 3 µM H2O2 + 50 µM 
EIP and 50 µM EIP are significantly lower than the values for the untreated controls and 3 µM H2O2. (B) 
Undamaged/damaged ratios were derived by dividing green biomass measurements by red biomass measurements.  
Treatments evaluated were 3 µM H2O2, 50 µM EIP, 3 µM H2O2 + 50 µM EIP, and untreated controls. ANOVA 
showed that the undamaged/damaged ratio significantly differs across the treatments (F [3,233] = 2951.10, p<0.05); 
post hoc tests show that the undamaged/damaged ratio for 50 µM EIP was significantly different from all other 
treatments (p<0.05). (C) Area layer was determined by COMSTAT analysis and is a measurement of the fraction of 
the area occupied by biomass (%) in each image of a stack (i.e. distance from the substratum (µM)).  The differences 
in the mean area layer of biofilms in each treatment group relative to biofilms of untreated controls were used to 
determine how the biofilm structure (from substratum to apex) was affected by our treatments.  A repeated measures 
ANOVA showed a significant effect on area layer by treatment condition; post hoc tests showed that treatments of 3 
µM H2O2 + 50 µM EIP and 50 µM EIP were significantly different than treatment with 3 µM H2O2 alone. 
 
31 
3.3.4 EIP and EIP + H2O2 disrupt the biofilm structure from substratum to apex 
Comparison of biofilm biomass after treatment with H2O2, EIP, and EIP + H2O2 revealed 
that the combination treatment of these compounds resulted in significant dispersal of P. 
aeruginosa biofilms, relative to untreated controls (Fig. 3.4A).  To determine if EIP + H2O2 affects 
the biomass distribution within the biofilm, the area layer function of COMSTAT was used to 
analyze CLSM-derived image stacks.  Area layer measures the fraction of the area occupied by 
biomass (%) in each image of a stack as a function of distance from the substratum.  By calculating 
the differences in the mean area layer of biofilms in each treatment group relative to biofilms of 
untreated controls, we determined how the biomass distribution within the biofilm was affected by 
the treatments (Fig. 3.4C).  Treatment with 3 µM H2O2 + 50 µM EIP or with 50 µM EIP led to a 
significant decrease in biomass from substratum to apex relative to the untreated controls.  On the 
other hand, 3 µM H2O2 alone caused biomass accumulation near the substratum relative to 
untreated controls.   
3.3.5 EIP and EIP + H2O2 enhances P. aeruginosa swimming motility 
To determine if biofilm dispersal, in the absence of increased membrane damage, was 
mediated through a motility mechanism, a series of agar plate-based motility assays were 
performed to test the effects of EIP on swimming, swarming, and twitching motility.  Initially, a 
concentration of 1 mM EIP was tested in order to account for the diffusion of the compounds 
through the agar matrix as well as compound stability over the duration of the assay.  These 
preliminary experiments showed that exposure to 1 mM EIP did not enhance or inhibit swarming 
or twitching motility; however, swimming motility was significantly enhanced relative to 
untreated controls (data not shown).  Subsequently, a series of EIP concentrations below 1 mM 
was tested (50, 100, 200, 400, 800 µM) to identify the range of effective treatment concentrations.  
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Motility was monitored over a period of 2 and 4 h to determine the duration of any effects.  
Exposure to 50 µM EIP did not result in a significant increase in swimming motility relative to 
untreated controls (Fig. 3.5).  However, only a 2-fold increase in concentration (100 µM EIP) was 
required to significantly enhance swimming motility relative to untreated controls.  This effect was 
observed over the course of 4 h (Fig. 3.5B).  To determine the combined effects of EIP + H2O2 on 
motility, concentrations used in biofilm dispersal assays (3 µM H2O2 and 50 µM EIP) were tested 
either alone or in combination, but they did not result in any enhancement in swimming motility 
over the course of 4 h (data not shown).  However, by increasing the H2O2 concentration 2-fold (6 
µM), its combined effect with 100 µM EIP enhanced P. aeruginosa swimming motility 
significantly (~80% after 2 h; ~40 % after 4 h), compared to each treatment alone and untreated 
controls (Fig. 3.6).   
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Figure 3.5: Effects of EIP on motility at 2 and 4 h. (A) Effects of 50, 100, 200, 400, and 
800 µM EIP on P. aeruginosa swimming motility after 2 h at 37°C.  Swimming motility 
for each treatment was quantified by measuring the diameter (mm) of each motility zone 
and calculating the area (mm2) of each zone after incubation.  Treatments are as follows: 
untreated control (PBM-no glucose) (black bar), 50 µM EIP (checkered bar), 100 µM EIP 
(dark gray bar), 200 µM EIP (light gray bar), 400 µM EIP (white bar), and 800 µM EIP 
(diagonal bar).  Values are means ± standard errors of the means for three replicates for 
each experimental condition. Treatments were normalized to untreated controls after taking 
the mean of the values for each of the control replicates.  An independent-samples Kruskal-
Wallis test indicated a significant effect of treatment on swimming motility (χ2(5) = 40.118, 
p<0.05) at 2 h.  Asterisk indicates that the mean rank values for treatments ≥ 100 µM EIP 
were significantly different than the mean rank values for the untreated control and 50 µM 
EIP (p<0.05).  (B) Same as panel A, except for 4 h incubation time rather than 2 h.  The 
Kruskal-Wallis test indicated a significant effect of treatment on swimming motility (χ2(5) 
= 40.399, p<0.05).  Asterisk indicates that the mean rank values for treatments ≥ 100 µM 
EIP were significantly different than the mean rank values for the untreated control and 50 
µM EIP (p<0.05).  
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Figure 3.6: Effects of EIP + H2O2 on motility at 2 and 4 h.  (A) Effects of 6 µM H2O2 + 
100 µM EIP on P. aeruginosa swimming motility at 2 h at 37°C. Swimming motility for each 
treatment was quantified by measuring the diameter (mm) of each motility zone and 
calculating the area (mm2) of each zone after incubation.  Treatments are as follows: untreated 
control (PBM-no glucose) (black bar). 100 µM EIP (dark gray bar), 6 µM H2O2 + 100 µM 
EIP (light gray bar), and 6 µM H2O2 (white bar). Values are means ± standard errors of the 
means for two replicates for each experimental condition. Treatments were normalized to 
untreated controls after taking the mean of the values for each of the control replicates.  An 
independent-samples Kruskal-Wallis test indicated a significant effect of treatment on 
swimming motility (χ2(3) = 30.251, p<0.05) at 2 h.  Asterisk indicates that the mean rank 
value for the 6 µM H2O2 + 100 µM EIP treatment was significantly different than the mean 
rank values for each compound alone and the untreated control (p<0.05).  (B) Same as panel 
A, except for 4 h incubation time rather than 2 h.  The Kruskal-Wallis test indicated a 
significant effect of treatment on swimming motility (χ2(3) = 14.530, p<0.05) at 4 h.  Asterisk 
indicates that the mean rank value for the 6 µM H2O + 100 µM EIP treatment was 
significantly different than the mean rank values for each compound alone and the untreated 
control (p<0.05).   
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3.4 Discussion 
Our results show that EIP + H2O2 acts in combination against P. aeruginosa biofilms at 
micromolar concentrations in two ways: prevention of biofilm formation and disruption of 
established biofilms.  Preventing biofilm formation is an important anti-biofilm strategy, and it 
encompasses the use of compounds that modulate gene expression linked to virulence factors, cell-
to-surface adhesion, and interference with exopolysaccharide production (71). However, in many 
cases, the specific mechanisms of agents that prevent biofilm formation have yet to be elucidated.  
The extent of biofilm inhibition caused by EIP + H2O2 is similar to the biofilm inhibiting effect 
caused by the Bacillus subtilis S8-18-derived α-amylase, a type of hydrolase that prevented biofilm 
formation in P. aeruginosa and other pathogens (72).  As is the case with α-amylases, EIP + H2O2 
could play a direct role in inhibiting biofilm formation by interference with bacterial adhesion, 
which is a critical step in initial biofilm formation and has been shown to occur within the first 
several hours in P. aeruginosa (73).  There is an ecological interpretation for the biofilm prevention 
activity of EIP + H2O2: Escapin, the L-amino acid oxidase from which EIP is derived, is a paralog 
of aplysianin A, an L-amino acid oxidase used by the sea hare A. californica to prevent microbial 
biofouling of its egg capsules (28, 58, 74).   
A notable finding of this work is the ability of H2O2 to inhibit P. aeruginosa biofilm 
formation at micromolar concentrations.  This is of particular interest due to the fact that millimolar 
concentrations are commonly used to trigger sublethal effects of oxidative stress in P. aeruginosa 
(75).  P. aeruginosa is adapted to detect and overcome oxidative stress, particularly at these low 
millimolar concentrations (76, 77).  Low millimolar concentrations of  H2O2 have been shown to 
actually enhance biofilm formation, most likely through a quorum sensing mechanism (78).  
Transcriptomic analyses have shown that exposure to H2O2 results in an increase in mRNA levels 
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of genes necessary to deal with oxidative stress as well as virulence factors (75).  These adaptive 
capabilities are not unique to P. aeruginosa.  Salmonella enterica Typhimurium becomes resistant 
to H2O2 treatments as high as 10 mM after exposure to sub-lethal concentrations of H2O2 (60 µM) 
(79).  Similar observations have also been reported in Escherichia coli (80).  However, here we 
have identified concentrations of H2O2 that when paired with EIP, inhibit biofilm formation at 
levels far below those commonly tested against P. aeruginosa.     
Oxidizing agents such as H2O2 have well-documented antimicrobial effects through DNA 
damage and oxygen radical toxicity (81, 82).  The antimicrobial effects are often more pronounced 
in planktonic cells as they are genotypically and phenotypically different from their biofilm 
counterparts and are generally more susceptible to treatments (77, 83).  In fact, this same pattern 
of susceptibility was observed in our antimicrobial treatment in that EIP + H2O2 was more effective 
against planktonic cultures of P. aeruginosa (1, 84).  In addition to inhibiting biofilm formation, 
the combination of EIP and H2O2 is effective against established P. aeruginosa biofilms at 
micromolar concentrations, which is at or below concentrations often used in published treatment 
assessments.  For example, Stewart et al. (77) showed that a steady treatment of 50 mM H2O2 for 
1 h had little effect on wild-type P. aeruginosa biofilms, a result linked to the combined effects of 
reduced penetration of the compound through the biofilm matrix and the protective role of catalase 
production in the biofilm.  Similarly, Bjarnsholt et al. (85) treated established P. aeruginosa 
biofilms with 100 mM H2O2 and demonstrated a decrease in susceptibility, most likely due to a 
quorum sensing mechanism.  Although microbial biofilms are generally less susceptible to the 
effects of H2O2, specifically at concentrations in the low millimolar range, our results suggest a 
treatment strategy in which H2O2 is effective at micromolar concentrations.       
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Disrupting established biofilms is a critical anti-biofilm strategy in applied contexts.  
Several factors promote detachment of P. aeruginosa, including enzymatic disruption of the 
surrounding extracellular polymeric substance (EPS) matrix, oxygen radical-dependent killing of 
bacteria (86), prophage-mediated bacterial death that enhances dispersal of cells from the biofilm 
(62), or the release of amyloid fibers linking cells in the biofilm together, a process regulated by 
D-amino acids (87).  Area layer analysis indicated that introduction of EIP, either alone or in 
combination with H2O2, significantly affected biofilm structure down to the substratum.  The fact 
that treatment with H2O2 alone appeared to have no significant structural effect on the biofilm was 
not completely unexpected.  In fact, H2O2-mediated cell lysis has been shown to contribute to 
extracellular DNA (eDNA) release in P. aeruginosa biofilms (88).  This eDNA release, coupled 
with poor penetration of the H2O2 through the biofilm matrix or its inactivation by catalases, could 
account for the largely unchanged biofilm structure, particularly at the substratum.  The 
introduction of EIP, on the other hand, either alone or in combination with H2O2, significantly 
affects biofilm structure, specifically down to the substratum.  EIP may not be susceptible to the 
same inactivation mechanisms seen with H2O2, which would allow it to penetrate and disrupt the 
biofilm matrix more effectively.  Since previous work with EIP in planktonic cultures suggested 
DNA condensation as a mechanism underlying its bactericidal properties (28), we initially 
hypothesized that EIP may be affecting the structural stability of the biofilm matrix by targeting 
the eDNA.  This is of particular importance because eDNA is an important structural component 
to P. aeruginosa biofilms and has been viewed as a viable target for biofilm disruption using 
enzymes such as DNase (89).  However, the possibility of EIP initiating biofilm dispersal through 
a motility-dependent mechanism was also considered.  Bacterial motility such as swimming, 
swarming (flagella-mediated) and twitching (type IV pili-mediated) are essential in P. aeruginosa 
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biofilm formation and maturation (90).  In fact, the enhancement of P. aeruginosa motilities, such 
as swimming, and its subsequent role in biofilm dispersal by compounds such as nitric oxide (91) 
and ginseng extracts (69) are well documented.  Interestingly, we determined that exposure to 1 
mM EIP significantly enhances swimming motility in P. aeruginosa when compared to untreated 
controls.  Follow-up experiments showed that concentrations as low as 100 µM EIP resulted in 
enhanced swimming motility relative to untreated controls, while pairing of 6 µM H2O2 + 100 µM 
EIP enhanced swimming motility to a greater degree than either compound alone.  This effect was 
observed over a period of 4 h and provides further support to the effectiveness of these compounds.  
Altogether, the coupling of EIP with hydroxyl radicals generated by H2O2, which have also been 
shown to trigger DNA damage (81, 92), results in a significant dispersal effect to established P. 
aeruginosa biofilms.    
There is additional significance in that the presence of endogenous H2O2 in the biofilm 
environment has been documented.  Liu et al. (93) measured H2O2 concentrations in the range of 
0.7–1.6 mM in Streptococcus gordonii biofilms and suggested that H2O2 concentrations can vary 
by species composition.  Likewise, many oral streptococci produce H2O2 as a means of competitive 
advantage (94).  The production of oxygen radicals, including H2O2 by polymorphonuclear 
leukocytes (PMNs) as means of eradicating microbial infections, is yet another potential source of 
endogenous H2O2 that could be encountered within a biofilm environment (85).  Thus, introduction 
of EIP alone could potentially enhance the inherent disruptive effects of H2O2 in these 
environments. 
EIP + H2O2 is a potentially valuable therapeutic for anti-virulence strategies, because it 
negatively impacts biofilm development and promotes dispersal at sub-lethal concentrations.  
Anti-virulence strategies are currently being pursued to overcome widespread microbial multi-
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drug resistance (14).  In general, these strategies aim to control microbial pathogenesis by targeting 
virulence mechanisms (e.g. cell adhesion, quorum sensing, biofilm formation, toxin production) 
while minimizing the selective pressure on the microorganisms that often leads to resistance (14, 
95).  Further investigation into the potential application of these compounds in combination with 
existing treatment strategies is both warranted and the focus of future work.  
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4 CONCLUSIONS 
Over the past twenty years, microbial biofilms have been investigated for their significant 
impact in both clinical and industrial settings (2).  The biofilm lifestyle allows microorganisms to 
colonize and establish complex communities in diverse environments.  It is important, therefore, 
to understand the factors that promote biofilm formation and maturation.  During the course of our 
investigations, we relied on methods for constructing polymicrobial biofilms with defined 
compositions in order to test various hypotheses regarding factors that influence biofilm 
establishment under antibiotic challenge.  Surface colonization is an important step in the biofilm 
formation process.  The amount of cells that colonize a given surface can ultimately affect the 
development of the biofilm as it matures, particularly under antibiotic pressure.  Nutrient 
availability also plays an important role in the biofilm lifestyle.  The presence or absence of 
nutrients can serve as an environmental cue, triggering phenotypic changes in cells that make them 
more or less resistant to antimicrobial treatments.  Future directions taking advantage of our 
described methods would be ideal for studying interactions between biofilms comprised of 
multiple pathogens.  For example, the sputum of cystic fibrosis patients has been characterized to 
contain pathogens such a P. aeruginosa and Staphylococcus aureus (96).  Indwelling devices, such 
as catheters, have also been shown to be colonized by various pathogens. Thus, modeling biofilm 
interactions is of extreme value, taking into consideration the mounting negative impact that 
biofilms and antibiotic resistance have on global health.  
Strategies to combat rising levels of antibiotic resistance are driven by the increases in 
multi-drug resistance in pathogenic bacteria.  Another major part of our investigation was to 
determine the efficacy of the novel antimicrobial treatment combination, EIP + H2O2, towards 
bacterial biofilms.  The combination of these compounds was previously determined to be 
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effective against planktonic cultures of bacteria.  Using P. aeruginosa as a model organism, we 
found that combination treatments of EIP + H2O2 were effective at inhibiting early biofilm 
formation as well as dispersal of pre-formed biofilms.  A key distinction of our findings was that 
treatment concentrations of our compounds were effective at the micromolar range, far below the 
millimolar ranges previously observed on planktonic cultures. For both biofilm inhibition and 
biofilm dispersal, combining EIP + H2O2 was more effective than each compound alone, 
suggesting a synergistic interaction between the compounds.  Inhibition was observed during early 
biofilm formation (< 4 h) at nearly 70% of untreated controls.  Biofilm dispersal of 24 h biofilms 
was observed at nearly 40% of untreated controls after only a 30 min treatment.  The role of EIP 
as a potential novel treatment strategy is particularly attractive due to its synergistic activity with 
H2O2, especially at low concentrations.  Hydrogen peroxide is readily encountered in microbial 
environments, particularly at wound sites, and therefore it may be possible to deliver EIP to wound 
sites and allow it to work with endogenous concentrations of H2O2.   
Based on calculated ratios of membrane damage (live/dead staining), we were able to 
determine that dispersal was not due to a bactericidal effect of the compounds.  In the absence of 
a bactericidal effect to account for dispersal, we hypothesized that a motility mechanism may be 
responsible for the dispersal activity.  This enhancement in motility was observed while 
performing motility assays, where combined treatments of EIP + H2O2, both at micromolar 
concentrations, resulted in increased swimming motility.  Future work should take these 
observations into account when establishing a clearer mechanism of action of our treatments, 
particularly against other well-known pathogens.  Additionally, future work should focus on the 
use of these compounds as possible adjuvants in combination with current antibiotic treatments.  
Potentiating antibiotics, potentially reducing the effective doses of current treatments, would add 
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yet another tool in the toolbox for combatting the impact of antibiotic resistance.  Overall, the 
application of EIP + H2O2 as an antibiofilm agent is quite promising.  
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